关注
Matthew Kurian
Matthew Kurian
未知所在单位机构
在 uhhospitals.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review
K Patell, M Kurian, JA Garcia, P Mendiratta, PC Barata, AY Jia, DE Spratt, ...
Expert Review of Anticancer Therapy 23 (7), 731-744, 2023
72023
Exploring real world outcomes with nivolumab plus ipilimumab in patients with metastatic extra-pulmonary neuroendocrine carcinoma (EP-NEC)
A Mohamed, N Vijayvergia, M Kurian, L Liu, P Fu, S Das
Cancers 14 (11), 2695, 2022
62022
A Novel approach to catheterizing the Left Gastric Artery for bariatric embolization
M Syed, W Efridi, T Khan, F Deek, M Kurian, A Shaikh
Radiology Case Reports 16 (11), 3574-3576, 2021
12021
The role of somatostatin analogue maintenance therapy in refractory metastatic neuroendocrine tumors (NETs): comparative analysis
A Mohamed, M Kurian, S Patil, SL Asa, SH Tirumani, A Mahipal, D Bajor, ...
Endocrine Abstracts 98, 2023
2023
Validation of the Plasmic Score and Development of a Novel Predictive Model for Thrombotic Thrombocytopenic Purpura: Exploring Socioeconomic Disparities and Outcomes
D Elantably, M Kurian, R Arroyo-Suárez, G Li, P Fu, I Tamaskar, ...
Blood 142, 2632, 2023
2023
Circulating tumor DNA (ctDNA) dynamics in response to checkpoint inhibitor immunotherapy in colorectal cancer.
K Patell, M Kurian, B Booker, M Chung, A Bennett, DL Bajor, ...
Journal of Clinical Oncology 41 (16_suppl), e15540-e15540, 2023
2023
Psoriasis Flare-Up in a Patient Treated With Docetaxel for Metastatic Prostate Cancer
M Kurian, K Patell, K Sekaran, KC Sekaran
Cureus 15 (2), 2023
2023
Vertebral augmentation-related Clostridium septicum osteomyelitis
N Pavlatos, M Kurian, O Khan, A Guehl, F Deek, A Shaikh, MI Syed
Radiology Case Reports 17 (10), 3779-3784, 2022
2022
Exploring Real World Outcomes of Ipilimumab and Nivolumab in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)
A Mohamed, N Vijayvergia, M Kurian, L Liu, F PingFu, S Das
PANCREAS 51 (3), E39-E39, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–9